betamethasone acetate phosphate
(JIWJMBWJUBGXRA-UIHQBSCNSA-L)
Structure
- SMILES
- O=C1C=C[C@]2(C(=C1)CC[C@@H]1[C@]2(F)[C@@H](O)C[C@]2([C@H]1C[C@@H]([C@]2(O)C(=O)COP(=O)([O-])[O-])C)C)C.CC(=O)CC(=O)[C@@]1(O)[C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)F.[Na+].[Na+]
- Molecular Formula:
- C46H59F2Na2O13P
- Molecular Weight:
- 934.903
- Log P:
- 5.7716
- Hydrogen Bond Acceptor:
- 13
- Hydrogen Bond Donor:
- 4
- TPSA:
- 248.5
- CAS Number(s):
- 8064-08-2
Synonym(s)
1.
betamethasone acetate phosphate
2.
Celestone Chronodose
3.
Celestone Soluspan
4.
Celestone-R
5.
betamethasone acetate phosphate, disodium salt
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Injection site pain | FAERS: 7 | US FAERS | |
| 2 | Injection site necrosis | FAERS: 6 | US FAERS | |
| 3 | Maternal exposure during pregnancy | FAERS: 5 | US FAERS | |
| 4 | Pain | FAERS: 4 | US FAERS | |
| 5 | Paraplegia | FAERS: 4 | US FAERS | |
| 6 | Wheelchair user | FAERS: 4 | US FAERS | |
| 7 | Agitation | FAERS: 2 | US FAERS | |
| 8 | Angioedema | FAERS: 2 | US FAERS | |
| 9 | Fatigue | FAERS: 2 | US FAERS | |
| 10 | Malaise | FAERS: 2 | US FAERS | |
| 11 | Mood swings | FAERS: 2 | US FAERS | |
| 12 | Abasia | FAERS: 1 | US FAERS | |
| 13 | Arthralgia | FAERS: 1 | US FAERS | |
| 14 | Asthenia | FAERS: 1 | US FAERS | |
| 15 | Cerebrovascular accident | FAERS: 1 | US FAERS | |
| 16 | Chest Pain | FAERS: 1 | US FAERS | |
| 17 | Cholecystitis | FAERS: 1 | US FAERS | |
| 18 | Drug effect incomplete | FAERS: 1 | US FAERS | |
| 19 | Erythema Infectiosum | FAERS: 1 | US FAERS | |
| 20 | Erythema | FAERS: 1 | US FAERS | |
| 21 | Feeling abnormal | FAERS: 1 | US FAERS | |
| 22 | HELLP Syndrome | FAERS: 1 | US FAERS | |
| 23 | Headache | FAERS: 1 | US FAERS | |
| 24 | Hemiplegia | FAERS: 1 | US FAERS | |
| 25 | Hypokinesia | FAERS: 1 | US FAERS | |
| 26 | Hypospadias | FAERS: 1 | US FAERS | |
| 27 | Impaired work ability | FAERS: 1 | US FAERS | |
| 28 | Incorrect route of drug administration | FAERS: 1 | US FAERS | |
| 29 | Infectious Mononucleosis | FAERS: 1 | US FAERS | |
| 30 | Laceration | FAERS: 1 | US FAERS | |
| 31 | Low birth weight baby | FAERS: 1 | US FAERS | |
| 32 | Mental impairment | FAERS: 1 | US FAERS | |
| 33 | Palpitations | FAERS: 1 | US FAERS | |
| 34 | Pancreatitis | FAERS: 1 | US FAERS | |
| 35 | Personality Change | FAERS: 1 | US FAERS | |
| 36 | Product contamination microbial | FAERS: 1 | US FAERS | |
| 37 | Product use in unapproved indication | FAERS: 1 | US FAERS | |
| 38 | Quadriplegia | FAERS: 1 | US FAERS | |
| 39 | Scedosporium infection | FAERS: 1 | US FAERS | |
| 40 | Symptom masked | FAERS: 1 | US FAERS | |
| 41 | Uterine Rupture | FAERS: 1 | US FAERS | |
| 42 | Vomiting | FAERS: 1 | US FAERS | |
| 43 | treatment failure | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.